ICSHBE 2027 国际癌症生物学、免疫治疗与临床药理学研讨会 (ICSHBE-CBICP 2027)

会议简介


The ICSHBE 2027 International Symposium on Cancer Biology, Immunotherapy and Clinical Pharmacology (ICSHBE-CBICP 2027) will be held on 19 January 2027 at Macau University of Science and Technology, Macao, China.


As a focused symposium of the 2nd International Conference on Smart Healthcare and Biomedical Engineering (ICSHBE 2027), the event provides an interdisciplinary platform for researchers, clinicians, biomedical engineers, pharmaceutical scientists and healthcare professionals to present recent developments in cancer research, immunotherapy and clinical pharmacology.


The symposium focuses on cancer biology, tumour immunology, precision oncology, targeted therapy, anticancer drug development, pharmacokinetics, clinical trials and intelligent healthcare technologies. It particularly welcomes studies connecting biomedical research with translational medicine and clinical practice.


Original research papers, review articles, methodological studies, clinical investigations and interdisciplinary applications are welcome. The symposium aims to encourage international academic exchange and promote safer and more effective approaches to cancer prevention, diagnosis and treatment.

论文收录


Accepted and registered papers will be published in the official symposium proceedings entitled Proceedings of the ICSHBE 2027 International Symposium on Cancer Biology, Immunotherapy and Clinical Pharmacology, abbreviated as Proceedings of ICSHBE-CBICP 2027.

Bibliographic metadata for published papers will be deposited with Crossref. Eligible papers will also be submitted to Google Scholar, CNKI, Conference Proceedings Citation Index (CPCI) and other relevant academic databases for evaluation and possible indexing.

Papers that have completed peer review, registration, final manuscript checks and production requirements may be transferred to publication on a regular basis. Papers registered earlier may enter the production process earlier.

Submission to an academic database does not guarantee inclusion or indexing. Final indexing results are determined independently by each database and may be affected by its evaluation criteria, policies, workflow and processing schedule.

征稿范围


1. Cancer Biology and Molecular Mechanisms


Molecular mechanisms of carcinogenesis


Cancer genetics and epigenetics


Oncogenes and tumour suppressor genes


Cell-cycle regulation in cancer


Cancer stem cells and tumour initiation


Tumour metabolism and metabolic reprogramming


DNA damage and repair mechanisms


Apoptosis, autophagy and cell death


Cancer invasion and metastasis


Biomarkers of tumour progression

2. Tumour Immunology and Immunotherapy


Tumour immune microenvironment


Immune-checkpoint inhibition


CAR-T and engineered immune-cell therapies


Cancer vaccines and therapeutic vaccination


Oncolytic viruses and viral immunotherapy


Monoclonal antibodies in cancer treatment


Innate immunity and tumour recognition


Immune resistance and tumour escape


Immunotherapy biomarkers


Combination immunotherapy strategies

3. Precision Oncology and Targeted Therapy


Precision cancer medicine


Molecularly targeted therapies


Genomic profiling in oncology


Liquid biopsy and circulating biomarkers


Companion diagnostics


Personalized treatment selection


Drug resistance and tumour evolution


Targeted drug-delivery systems


Nanomedicine in cancer therapy


Combination and multimodal cancer treatment

4. Anticancer Drug Discovery and Pharmacology


Discovery of novel anticancer agents


Drug screening and lead optimization


Natural products in cancer therapy


Pharmacodynamics of anticancer drugs


Pharmacokinetics and drug metabolism


Preclinical pharmacology and toxicology


Drug interactions in oncology


Formulation and pharmaceutical development


Biologics and biosimilars in oncology


Drug repurposing for cancer treatment

5. Clinical Oncology and Clinical Pharmacology


Clinical trials in oncology


Clinical pharmacokinetics and dose optimization


Therapeutic drug monitoring


Pharmacogenomics and individualized dosing


Adverse drug reactions and patient safety


Real-world evidence in cancer treatment


Supportive and palliative cancer care


Paediatric and geriatric oncology


Clinical treatment guidelines and pathways


Patient-reported outcomes and quality of life

6. Smart Healthcare and Translational Oncology


Artificial intelligence in cancer diagnosis


Machine learning for treatment prediction


Medical imaging and radiomics


Digital pathology and computational pathology


Multi-omics data integration


Bioinformatics in cancer research


Digital biomarkers and remote monitoring


Biomedical devices for cancer care


Translational models and organoid platforms


Clinical decision-support systems in oncology